Probiotics News and Research

RSS

Daily probiotics help prevent severe gut disease in preterm babies

Probiotic supplementation in very preterm infants is linked to lower rates of necrotizing enterocolitis and mortality, according to a nationwide Swedish study.

30 Sep 2026

Why one gut microbe is attracting attention in heart failure research

Researchers found that chronic systolic heart failure caused by nonischemic cardiomyopathy was associated with reduced gut microbial diversity, depletion of Bifidobacterium, and lower microbial short-chain fatty acid production potential. Higher Bifidobacterium abundance and higher circulating indole-3-propionic acid levels were associated with milder disease and clinical improvement, although the findings do not establish causality.

27 Sep 2026

Gut bacteria metabolites directly extend the lifespan of host flies

Gut microbiota influences multiple aspects of host physiology, including metabolic and immune functions.

24 Sep 2026

Fermented dairy was linked to lower mortality, but the pattern shifted at higher intakes

Analysis of 37,366 US adults found that fermented dairy consumption was associated with lower all-cause and cardiovascular mortality, with consumers showing adjusted hazards 18% and 20% lower, respectively, than non-consumers. Dose-response analyses indicated that the inverse association was concentrated at intakes below about 150 grams per day, while the observational study could not establish causality.

16 Sep 2026

Simple fecal test could help detect colorectal and pancreatic cancers

Gastrointestinal and pancreatobiliary cancers can be difficult to detect early, creating a need for practical, noninvasive approaches for early detection and risk assessment.

16 Sep 2026

C. diff uses dual-threat sensing system to survive gut stress

The pathogen Clostridioides difficile (C. diff) - a leading cause of hospital-acquired infections - must contend with a variety of threats inside the harsh environment of the gut to survive and grow.

9 Sep 2026

Scientists found a distinct gut microbiome pattern in people with symptomatic diverticular disease

A multicenter Japanese study found that symptomatic uncomplicated diverticular disease (SUDD) was associated with reduced gut microbial diversity, increased abundance of the Ruminococcus gnavus group, and depletion of Coprococcus and other butyrate-producing bacteria. Predictive microbiome analysis also identified enrichment of pathways linked to exopolysaccharide biosynthesis and the cell cycle, although the observational design means these associations cannot establish causality.

25 Aug 2026

Cocoa looks promising for mood, but the brain benefits come with a catch

A review of clinical and preclinical studies suggests cocoa polyphenols may support mood, neuroplasticity, cerebral blood flow, and gut-brain signaling through pathways involving BDNF/CREB, inflammation, and oxidative stress.

17 Aug 2026

Biotherapeutic metabolite repairs gut damage caused by HIV infection

Researchers at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy (ART) in the nonhuman primate model of HIV/AIDS.

30 Jul 2026

Microbial metabolites could help improve functional cure rates for hepatitis B

Chronic hepatitis B (CHB) remains a major global challenge. Current therapies suppress HBV but rarely achieve functional cure (sustained HBsAg loss).

30 Jul 2026

Jet lag may disrupt athletes' gut microbiome and slow recovery

The interplay between jet lag and gut microbiome affects athlete performance. Strategies to manage these disruptions are crucial but not yet fully established.

30 Jul 2026

Duke University engineers use robots and AI to improve gut health

Biomedical engineers at Duke University have demonstrated a method for systematically developing novel, complex combinations of probiotics and prebiotics to more effectively maintain gut health and treat various gastrointestinal diseases.

27 Jul 2026

Gut microbial metabolites may shape vulnerability to stress-related mental disorders

Gut microbiome-derived metabolites may influence stress-related mental disorders through neural, immune, endocrine, and epigenetic pathways. Evidence is strongest for depression and preclinical models, while larger longitudinal human studies are needed to establish causality and clinical value.

20 Jul 2026

Maternal diets high in UPFs may influence children’s health years later

A narrative review of 84 publications links higher ultra-processed food intake during pregnancy and early childhood with poorer diet quality, maternal complications, childhood obesity, and potential immune, metabolic, and neurodevelopmental effects. The authors identify possible microbiome and biopsychosocial pathways but emphasize that the predominantly observational evidence cannot establish causality.

17 Jul 2026

Study links chronic xanthan gum consumption to colon inflammation

Xanthan gum is found almost everywhere. This food additive has thickening, stabilizing, and gelling properties and is one of the most widely used by the food industry to adjust the consistency of ice cream, yogurt, cakes, sauces, and gluten-free pasta.

13 Jul 2026

Gut microbiota may shape eating behavior and guide new obesity treatments

The review shows how gut microbiota may influence appetite, food reward, inflammation, and energy balance through the gut-brain axis. Microbiota-targeted approaches could support future treatments for obesity and eating disorders, but clinical evidence remains limited.

12 Jul 2026

Yogurt, prebiotics, and probiotics link to lower colorectal cancer odds in U.S. adults

A national NHANES analysis of 9,405 U.S. adults aged 50 and older found that any yogurt, prebiotic, or probiotic consumption was associated with about 50% lower odds of self-reported colorectal cancer. Because the study was cross-sectional, it cannot prove causation but supports further research into microbiota-targeted dietary strategies.

8 Jul 2026

Microbiome science merges with oncology for better cancer treatments

Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the resident microbiota, to evade immune surveillance and resist conventional therapies.

7 Jul 2026

Altering gut microbes could improve immunotherapy responses in liver cancer

Immune checkpoint blockade (ICB) has reshaped the treatment landscape for advanced hepatocellular carcinoma (HCC), offering new hope where few options existed.

30 Jun 2026

Gut microbes emerge as potential players in estrogen-driven cancers

A new review maps how the endocrine-microbiome axis expands the estrobolome concept, showing that gut microbes may alter estrogen recycling, produce hormone-like metabolites, and shape inflammation and tissue environments in hormone-driven cancers. Human evidence remains mostly associative, so the authors call for causal models, longitudinal multi-omics, multi-kingdom profiling, and sex-stratified studies before microbiome-guided cancer strategies enter routine care.

25 Jun 2026